Fluorouracil

Articles · Lactation Safety Information ·
3127006

Articles

Lactation Safety Information

Parenteral

Parenteral
Very limited published evidence indicates negligible levels in breast milk
If used as monotherapy do not resume breastfeeding until at least 24 hours after a dose, and monitor infant’s blood count
Discontinue breastfeeding if used in combination with other antineoplastics
3rd August 2020

Topical

Topical
Imiquimod
Avoid use on large areas of skin
3rd August 2020